All News
STAT+: Device maker Zynex Medical under pressure from insurers, SEC filings show
Zynex Medical disclosed that an insurer, a major client, was suspending payments and reviewing prior claims.
Read MoreCompounding Quality Center of Excellence | Engage with the Compounding Quality Center of Excellence
Engage with the Compounding Quality Center of Excellence
Read MoreFDA to Compounders: Know Your Bulks and Excipients Suppliers
FDA has identified several issues over the past few years related to repackers of bulk drug substances, also called active pharmaceutical ingredients (APIs), used to compound drugs.
Read MoreOpinion: How to protect the American egg supply from avian flu
The most effective strategy against bird flu on chicken farms is prevention, writes former FDA Commissioner Scott Gottlieb — and that may include vaccinating chicks.
Read MoreHow Covid changed the British state
Surge in national debt and NHS backlog altered the economy and expectations around crisis managementAt 9.
Read MoreCould a Novel Treatment Modality Change the Trajectory of Amyloidosis Care?
(MedPage Today) -- For U.S.
Read MoreColonoscopy and AI: Experts weigh fuzzy evidence of benefit
In this edition of STAT's Health Tech newsletter: Does evidence support wider adoption of AI-assisted colonoscopies?
Read MoreBiotech stocks get boost from Fed rate outlook
And other biotech news brought to you by The Readout.
Read MoreFood Recall Over 'Wood-Like' Substance; Hospital Shooting; U.S. Losing Happiness
(MedPage Today) -- Note that some links may require registration or subscription. MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts.
Read MoreGDUFA Implementation Quarterly Meetings between FDA and Industry
FDA and representatives of the generic drug industry meet quarterly to discuss topics related to the implementation of GDUFA.
Read More